Crescent Grove Advisors, LLC Dexcom Inc Transaction History

Crescent Grove Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 22, 2024	BUY	$110.31 - $140.45 $241,909 - $308,006	2,193 New	2,193 $248,000
Q2 2023 Jul 13, 2023	BUY	$112.47 - $130.98 $225,164 - $262,221	2,002 New	2,002 $257,000
Q2 2022 Jul 20, 2022	SELL	$67.99 - $132.89 $31,275 - $61,129	-460 Closed	0 $0
Q4 2021 Jan 24, 2022	BUY	$129.87 - $162.82 $59,740 - $74,897	460 New	460 $247,000

1,016

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $30.1B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Crescent Grove Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Crescent Grove Advisors, LLC with notifications on news.